asthma
Conditions
Interventions
Experimental group:Danlong oral liquid,10ml per time, 3 times per day, for 7 days
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients meet the diagnostic criteria for asthma; (2) Patients meet the diagnostic criteria for heat asthma syndrome; (3) Aged over 18 years, male or female; (4) Volunteered to participate in the trial, and signed the written informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe or life threatening asthma exacerbation; (2) Patients with well controlled asthma; (3) Patients with pulmonary fibrosis, tuberculosis, bronchiectasis; (4) Patients with severe cardiovascular, cerebrovascular, hematopoietic and other serious diseases (5) Pregnant or breastfeeding women, and male patients with plans for fertility; (6) Patients who were allergic to the components of the study drug; (7) Patients with intellectual or mental disorder; (8) Patients with long-term history of alcohol and drug abuse; (9) Patients who have participated in clinical trials of other drugs within 3 months; (10) Patients considered unsuitable for participation by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Asthma Control Questionnaire;TCM syndrom scores; | — |
Countries
China
Contacts
Public ContactHongchun ZHANG
China-Japan Friendship Hospital
Outcome results
None listed